Endusamycin, with the CAS number 100242-41-9, is a natural product that belongs to the class of compounds known as antibiotics. It is derived from the fermentation of certain bacterial strains, particularly those in the genus Streptomyces. Endusamycin exhibits a unique structure characterized by a complex bicyclic core, which contributes to its biological activity. This compound has shown promising antibacterial properties, particularly against Gram-positive bacteria, making it a subject of interest in pharmaceutical research. Its mechanism of action typically involves interference with bacterial cell wall synthesis, leading to cell lysis and death. Additionally, endusamycin may possess antitumor activity, although further studies are needed to fully understand its potential in cancer therapy. The compound's stability, solubility, and bioavailability are important factors that influence its efficacy and application in medicinal chemistry. Overall, endusamycin represents a valuable lead compound in the search for new antibiotics and therapeutic agents.

endusamycin

100242-41-9: Endusamycin, with the CAS number 100242-41-9, is a natural product that belongs to the class of compounds known as antibiotics. It is derived from the fermentation of certain bacterial strains, particularly those in the genus Streptomyces. Endusamycin exhibits a unique structure characterized by a complex bicyclic core, which contributes to its biological activity. This compound has shown promising antibacterial properties, particularly against Gram-positive bacteria, making it a subject of interest in pharmaceutical research. Its mechanism of action typically involves interference with bacterial cell wall synthesis, leading to cell lysis and death. Additionally, endusamycin may possess antitumor activity, although further studies are needed to fully understand its potential in cancer therapy. The compound's stability, solubility, and bioavailability are important factors that influence its efficacy and application in medicinal chemistry. Overall, endusamycin represents a valuable lead compound in the search for new antibiotics and therapeutic agents.

Endusamycin inhibits protein and nucleic acid synthesis in Ehrlich ascites carcinoma cells but does not exhibit antibacterial or anti-yeast activity.

CAS 100242-41-9

endusamycin

Endusamycin

Ref: TM-TN10241